Header menu link for other important links
Virtual Screening of Peptidyl Arginine Deiminase Type 4 Inhibiting Potential of Chosen Flavonoids
Udhaya Lavinya B, , Manisha P, , ,
Published in Diva Enterprises Private Limited
Volume: 11
Issue: 2

Peptidyl arginine deaminase type 4 (PADI4) has been identified as a potential therapeutic target for rheumatoid arthritis. The aim of current study was to screen 20 chosen flavonoids for PADI4 (PDB Id.: 4X8C) inhibiting potential. The compounds were docked using PatchDock online server for molecular docking. The docked complex was visualized and the interacting patterns were analysed using PyMol software. The results revealed that compounds such as bacopaside II and X, canthaxanthine and broussonol E showed significant interaction with 4X8C with docking scores of 7864, 8432, 7962 and 8544. The study shows binding and interaction patterns of the chosen flavonoids with 4X8C. However, these compounds need to be explored for anti-arthritic activity.

About the journal
JournalResearch Journal of Pharmacy and Technology
PublisherDiva Enterprises Private Limited
Open Access0
Authors (4)